StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lipella Pharmaceuticals's revenue for the twelve months ending Sep 30, 2025 was $389.78K, down 19.4% year over year. For fiscal 2024 it was $536.36K, up 19.3% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$536.36K+19.3%
FY2023Dec 31, 2023$449.62K+144.2%
FY2022Dec 31, 2022$184.16K-29.0%
FY2021Dec 31, 2021$259.35K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$86.73K-36.4%
Q1 FY2025Mar 31, 2025$129.39K-11.3%
Q4 FY2024Dec 31, 2024$173.67K+43.7%
Q3 FY2024Sep 30, 2024$80.38K-22.7%
Q2 FY2024Jun 30, 2024$136.43K+27.9%
Q1 FY2024Mar 31, 2024$145.88K+23.6%
Q4 FY2023Dec 31, 2023$120.84K-20.0%
Q3 FY2023Sep 30, 2023$104.05K–
Q2 FY2023Jun 30, 2023$106.68K–
Q1 FY2023Mar 31, 2023$118.05K+256.1%
Q4 FY2022Dec 31, 2022$151.01K–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$33.15K–

More Lipella Pharmaceuticals figures

See a number that looks wrong?